AMAG

AMAG Pharmaceuticals, Inc. News Headlines

$44.17
*  
0.87
2.01%
Get AMAG Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading AMAG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
bluebird bio (BLUE) Soars on Data from LentiGlobin Study - Analyst Blog
12/11/2014 4:45:00 PM - Zacks.com


Celldex's Glembatumumab Vedotin in Phase II for Melanoma - Analyst Blog
12/5/2014 3:10:00 PM - Zacks.com


Bayer Files Hemophilia A Drug Marketing Application in EU - Analyst Blog
12/5/2014 10:20:00 AM - Zacks.com


CytRx Falls on Written FDA Notice for Aldoxorubicin Study - Analyst Blog
12/4/2014 5:20:00 PM - Zacks.com


Regeneron at 52-Week High on Eylea Priority Review Status - Analyst Blog
12/4/2014 9:15:00 AM - Zacks.com


Oncolytics Files for Orphan Drug Designation for Reolysin - Analyst Blog
12/3/2014 4:30:00 PM - Zacks.com


AMAG Pharma (AMAG) Shares March Higher, Can It Continue? - Tale of the Tape
12/3/2014 9:35:55 AM - Zacks.com


Mylan, Gilead Ink Deal for TAF-based HIV Drugs - Analyst Blog
12/2/2014 5:45:00 PM - Zacks.com


Celgene Hits 52-Week High on Positive CHMP Opinion - Analyst Blog
12/1/2014 3:14:00 PM - Zacks.com


Alexion's Soliris Gets Final Positive NICE Recommendation - Analyst Blog
11/28/2014 5:00:00 PM - Zacks.com


Mylan (MYL) Sued By Baxter for Generic Filing of Brevibloc - Analyst Blog
11/28/2014 4:30:00 PM - Zacks.com


Merge Healthcare, Primordial to Improve Radiology Solutions - Analyst Blog
11/28/2014 4:20:00 PM - Zacks.com


Glaxo's Ebola Candidate Well-Tolerated in Early U.S. Study - Analyst Blog
11/28/2014 11:49:00 AM - Zacks.com


uniQure N.V. (QURE) in Focus: Stock Soars 17.6% - Tale of the Tape
11/28/2014 9:21:00 AM - Zacks.com


Coronado Biosciences, Inc. (CNDO) in Focus: Stock Soars 17.6% - Tale of the Tape
11/28/2014 9:18:00 AM - Zacks.com


Oncothyreon Inc. (ONTY) in Focus: Stock Surges 10.1% - Tale of the Tape
11/28/2014 8:44:00 AM - Zacks.com


AMAG Pharmaceuticals (AMAG): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
11/28/2014 8:43:00 AM - Zacks.com


Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog
11/26/2014 5:10:00 PM - Zacks.com


Isis Pharmaceuticals Earns Milestone on Study Initiation - Analyst Blog
11/26/2014 5:00:00 PM - Zacks.com


Five Prime Therapeutics Up on Deal with Bristol-Myers - Analyst Blog
11/26/2014 4:30:00 PM - Zacks.com


Strength Seen in Kythera (KYTH): Stock Moves 5.5% Higher - Tale of the Tape
11/26/2014 9:25:00 AM - Zacks.com


What Makes BioDelivery Sciences (BDSI) a Strong Sell? - Tale of the Tape
11/26/2014 8:38:00 AM - Zacks.com


Endo to Acquire Rights to Testosterone Nasal Gel Natesto - Analyst Blog
11/25/2014 6:00:00 PM - Zacks.com


Five Prime Therapeutics, Inc. (FPRX) in Focus: Stock Soars 31.4% - Tale of the Tape
11/25/2014 9:18:00 AM - Zacks.com


Coronado Biosciences (CNDO) Jumps: Stock Rises 8.5% - Tale of the Tape
11/25/2014 8:51:00 AM - Zacks.com